Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series

OBJECTIVES: To investigate the efficacy and safety of Vancomycin Ophthalmic Ointment 1% (Toa Pharmaceutical Co., Ltd, Toyama, Japan) in patients with external ocular infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-resistant Staphylococcus epidermidis (MRSE). DE...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sotozono, Chie, Fukuda, Masahiko, Ohishi, Masao, Yano, Keiko, Origasa, Hideki, Saiki, Yoshinori, Shimomura, Yoshikazu, Kinoshita, Shigeru
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2013
Gaiak:
Ophthalmology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563129/
https://ncbi.nlm.nih.gov/pubmed/23364319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2012-001206
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak